1. Strehle EM and Shabde N. One hundred years of telemedicine: does this new technology have a place in paediatrics? Arch Dis Child. 2006;91(12):956-9.
2. Achey M et al. The past, present, and future of telemedicine for Parkinson's disease. Mov Disord. 2014;29(7):871-83.
3. WHO. Atlas Country Resources for Neurological Disorders. Second Edition 2017. ISBN: 978-92-4-156550-9
4. Radder DLM et al. Multidisciplinary care for people with Parkinson’s disease: the new kids on the block! Expert Rev Neurother. 2019;19(2):145-57.
5. Ben-Pazi H et al. The promise of telemedicine for movement disorders: An interdisciplinary approach. Curr Neurol Neurosci Rep. 2018;18(5):26.
6. Sekimoto S et al. A randomized crossover pilot study of telemedicine delivered via ipads in Parkinson’s disease. Parkinson’s Disease. 2019;Article #9403295.
7. Dorsey ER et al. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov Disord. 2010;25(11):1652-9.
8. Silva de Lima AL et al. Home‐based monitoring of falls using wearable sensors in Parkinson's disease. Mov Disord. 2019;26 Aug Epub: https://doi.org/10.1002/mds.27830
9. Delprato U et al. PARKSERVICE: Home support and walking aid for people with Parkinson's disease. Stud Health Technol Inform. 2006;121:1-6.
10. Dias AE et al. Voice telerehabilitation in Parkinson's disease. Codas. 2016;28(2):176-81.
11. Ward EC et al. Validity of conducting clinical dysphagia assessments for patients with normal to mild cognitive impairment via telerehabilitation. Dysphagia. 2012;27(4):460-72.
12. Gandolfi M et al. Virtual reality telerehabilitation for postural instability in Parkinson's disease: A multicenter, single-blind, randomized, controlled trial. Biomed Res Int. 2017:7962826.
13. Li D et al. Remotely programmed deep brain stimulation of the bilateral subthalamic nucleus for the treatment of primary Parkinson disease: a randomized controlled trial investigating the safety and efficacy of a novel deep brain stimulation system. Stereotact Funct Neurosurg. 2017;95(3):174-82.
14. Willows T et al. Initiation of levodopa-carbidopa intestinal gel infusion using telemedicine (video communication system) facilitates efficient and well-accepted home titration in patients with advanced Parkinson's disease. J Parkinsons Dis. 2017;7(4):719-28.
15. Butterfield LC et al. The Parkinson's Active Living (PAL) Program. J Geriatr Psychiatry Neurol. 2017;30(1):11-25.
16. Pretzer-Aboff I and Prettyman A. Implementation of an integrative holistic healthcare model for people living with Parkinson's disease. Gerontologist. 2015;55(Suppl 1):S146-53.
17. Schneider RB and Biglan KM. The promise of telemedicine for chronic neurological disorders: the example of Parkinson's disease. Lancet Neurol. 2017;16(7):541-51.
18. Spindler M and Martin J. Telemedicine in your movement disorders practice: A step-by-step guide. December 2018. https://www.movementdisorders.org/MDS/About/Committees--Other-Groups/Tel... (Accessed 24 September 2019).
19. Patel UK et al. Multidisciplinary approach and outcomes of tele-neurology: A review. Cureus. 2019;11(4):e4410.
20. Cubo E et al. A Parkinson's disease tele-education program for health care providers in Cameroon. J Neurol Sci. 2015;357(1-2):285-7.
21. Chirra M et al. Telemedicine in neurological disorders: Opportunities and challenges. Telemedicine and e-Health 2019;25(7): 11 July Epub: https://doi.org/10.1089/tmj.2018.0101.